Biomea Fusion, Inc. BMEA
0.57 USD -0.01 (-2.38%)
Regular-session close
0.60 +0.02 +3.93%
After hours · Nov 20, 7:51 PM ET
0.5445 Day range 0.60
0.488 52-week range 2.21
- YTD
- -53.68%
- 1 year
- -42.56%
News
benzinga.com Why Gap Shares Are Trading Higher By Around 4%; Here Are 20 Stocks Moving Premarket Gap shares rise 3.8% after Q3 EPS beat estimates; Athleta names new CEO. Erayak and NewGenIvf lead gainers, Solmate leads losers.benzinga.com Biomea Fusion Q3 EPS $(0.09) Beats $(0.21) Estimate Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.21) by 57.14 percent. This is a 66.67 percent increase over losses of…
benzinga.com Biomea Fusion To Present Phase 1 Clinical Results For BMF-650, Investigational Next-Gen Oral Small Molecule GLP-1 Receptor Agonist, At ObesityWeek 2026 Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage biopharmaceutical company focused on diabetes and obesity, today announced that it will present Phase 1 clinical results for BMF-650, its
